These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9625742)

  • 1. Actin microfilaments control the MHC class II antigen presentation pathway in B cells.
    Barois N; Forquet F; Davoust J
    J Cell Sci; 1998 Jul; 111 ( Pt 13)():1791-800. PubMed ID: 9625742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the alpha- and beta-chains.
    Théry C; Brachet V; Regnault A; Rescigno M; Ricciardi-Castagnoli P; Bonnerot C; Amigorena S
    J Immunol; 1998 Sep; 161(5):2106-13. PubMed ID: 9725201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments.
    Castellino F; Germain RN
    Immunity; 1995 Jan; 2(1):73-88. PubMed ID: 7600303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.
    Robbins NF; Hammond C; Denzin LK; Pan M; Cresswell P
    Hum Immunol; 1996 Jan; 45(1):13-23. PubMed ID: 8655355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes.
    Brachet V; Raposo G; Amigorena S; Mellman I
    J Cell Biol; 1997 Apr; 137(1):51-65. PubMed ID: 9105036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular transport of MHC class II and associated invariant chain in antigen presenting cells from AP-3-deficient mocha mice.
    Sevilla LM; Richter SS; Miller J
    Cell Immunol; 2001 Jun; 210(2):143-53. PubMed ID: 11520080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
    Warmerdam PA; Long EO; Roche PA
    J Cell Biol; 1996 Apr; 133(2):281-91. PubMed ID: 8609162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
    Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
    Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments.
    McCormick PJ; Martina JA; Bonifacino JS
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7910-5. PubMed ID: 15911768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class II molecules traffic into lipid rafts during intracellular transport.
    Poloso NJ; Muntasell A; Roche PA
    J Immunol; 2004 Oct; 173(7):4539-46. PubMed ID: 15383586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
    Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
    J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation.
    Barois N; Forquet F; Davoust J
    J Biol Chem; 1997 Feb; 272(6):3641-7. PubMed ID: 9013617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient internalization of MHC class II-invariant chain complexes is not sufficient for invariant chain proteolysis and class II antigen presentation.
    Swier K; Miller J
    J Immunol; 1995 Jul; 155(2):630-43. PubMed ID: 7608541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endosomal localization of MHC class II-invariant chain complexes.
    Miller J
    Immunol Res; 1994; 13(4):244-52. PubMed ID: 7616052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of major histocompatibility complex class II compartments during B cell receptor-mediated cell activation.
    Lankar D; Vincent-Schneider H; Briken V; Yokozeki T; Raposo G; Bonnerot C
    J Exp Med; 2002 Feb; 195(4):461-72. PubMed ID: 11854359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments.
    Kleijmeer MJ; Morkowski S; Griffith JM; Rudensky AY; Geuze HJ
    J Cell Biol; 1997 Nov; 139(3):639-49. PubMed ID: 9348281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
    Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
    J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
    Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
    J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.